|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash flows from operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Impairment of Long-Lived Assets Held-for-use | |||||
| Lease-related impairment charges | |||||
| Share-based compensation | |||||
| Amortization of debt discount and issuance costs | |||||
| Allowances for doubtful accounts | |||||
| Deferred income taxes | |||||
| (Gains) losses on sale of property and equipment | |||||
| Gain on sale of businesses, excluding transaction costs | |||||
| Change in fair value of contingent consideration liabilities | |||||
| Change in fair value of preferred stock investment | |||||
| Other, net | |||||
| Credit-related impairment charge on convertible debt investment | |||||
| Changes in operating assets and liabilities, net of acquisitions and divestiture: | |||||
| (Increase) decrease in receivables from clients, net | |||||
| (Increase) decrease in unbilled services, net | |||||
| (Increase) decrease in current income tax receivable / payable, net | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in accounts payable and other liabilities | |||||
| Increase (decrease) in accrued payroll and related benefits | |||||
| Increase (decrease) in deferred revenues | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Investments in life insurance policies | |||||
| Distributions from life insurance policies | |||||
| Purchases of businesses, net of cash acquired | |||||
| Capitalization of internally developed software costs | |||||
| Proceeds from note receivable | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from divestitures of businesses | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercises of stock options | |||||
| Shares redeemed for employee tax withholdings | |||||
| Share repurchases | |||||
| Proceeds from bank borrowings | |||||
| Repayments of bank borrowings | |||||
| Payments for debt issuance costs | |||||
| Deferred payments on business acquisition | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at end of the period | |||||
| Cash and cash equivalents at beginning of the period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Non-cash investing and financing activities: | |||||
| Property and equipment expenditures and capitalized software included in current liabilities | |||||
| Contingent consideration related to purchases of businesses | |||||
| Common stock issued related to purchases of businesses | |||||
| Contingent consideration accrued related to purchases of businesses | |||||
| Notes Issued | |||||
| Share Repurchases Initiated but not yet Settled | |||||
| Excise tax on net share repurchases incurred but not paid | |||||
| Interest | |||||
| Income taxes | |||||
Loading...